ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-OR39

Evaluation of Renal Blood Flow Using 64Cu-ATSM PET

Session Information

Category: Bioengineering

  • 300 Bioengineering

Authors

  • Takahashi, Naoki, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Nishikawa, Yudai, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Nishikawa, Sho, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Shimamoto, Yuki, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Nishimori, Kazuhisa, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Fukushima, Sachiko, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Morita, Sayu, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Kobayashi, Mamiko, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Kimura, Hideki, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Kasuno, Kenji, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Ikawa, Masamichi, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Tujikawa, Tetsuya, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Okazawa, Hidehiko, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
  • Iwano, Masayuki, Fukui Daigaku Igakubu, Yoshida-gun, Fukui, Japan
Background

In patients with CKD, it is important to evaluate renal blood flow (RBF). RBF can be obtained by the clearance method, estimation from eGFR or measurement using nuclear medicine test, but all have their advantages and disadvantages. For this reason, a method to assess RBF with ASL-MRI has recently been investigated and has been shown to be reliable. Cu(II)-diacetyl-bis(4-methylthiosemicarbazonate) (Cu-ATSM) is a tracer developed for hypoxia imaging and has been reported to be able to quantify cerebral blood flow. Therefore, in this study, we performed ASL-MRI and PET imaging simultaneously and obtained the actual RBF values. Furthermore, we compared the estimated RBF (eRBF) obtained from clinical parameters with the measured RBF of both imaging methods and investigated the usefulness of PET for the evaluation of RBF.

Methods

The study consisted of 15 subjects, including 5 healthy subjects and 10 patients with various CKD. A single dose of 300-400 MBq 64Cu-ATSM was administered, the abdomen was imaged for PET, and then ASL images were taken. Circular ROIs were placed on the upper to lower poles of the kidney cortex for PET/MRI imaging. To obtain an RBF, the mean of the 20 ROI values was calculated. eGFR was calculated from serum creatinine (sCr) and cystatin C (sCys), respectively, and eRBF was calculated using the eGFR, hematocrit and FF values. Furthermore, renal volume was calculated by integrating MRI and eRBF per 100 g of kidney weight was calculated.

Results

The RBF measured with MRI-ASL was positively correlated with eRBF by sCr (r=0.596, p<0.05) and sCys (r=0.669, p<0.01), respectively. The RBF measured with 64Cu-ATSM was positively correlated with the RBF estimated by sCr (r=0.621, p<0.05) and sCys (r=0.591, p=0.02), respectively. The RBF measured with MRI-ASL was positively correlated with the RBF measured with 64Cu-ATSM (r=0.714, p=0.003). The linear regression line had a slope close to 1 (0.88) and the intercept (14.1) also approximated the origin. The Bland-Altman analysis showed agreement with the RBF measured by ASL imaging and 64Cu-ATSM imaging (Bias=-2.4, SD=24.9).

Conclusion

We report for the first time that 64Cu-ATSM PET is useful for assessing RBF in healthy subjects and patients with various renal diseases, as well as ASL-MRI.

Funding

  • Government Support – Non-U.S.